Artivion (AORT) Stock Forecast & Price Target $41.00 +0.37 (+0.91%) Closing price 03:58 PM EasternExtended Trading$41.72 +0.72 (+1.76%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Artivion - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating Moderate BuyBased on 9 Analyst RatingsSell1Hold1Buy7 Based on 9 Wall Street analysts who have issued ratings for Artivion in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 1 has given a sell rating, 1 has given a hold rating, 6 have given a buy rating, and 1 has given a strong buy rating for AORT. Consensus Price Target $43.977.24% Upside According to the 9 analysts' twelve-month price targets for Artivion, the average price target is $43.97. The highest price target for AORT is $50.00, while the lowest price target for AORT is $32.00. The average price target represents a forecasted upside of 7.24% from the current price of $41.00. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for AORT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Artivion and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AORT Analyst Ratings Over TimeTypeCurrent Forecast10/14/24 to 10/14/251 Month Ago9/14/24 to 9/14/253 Months Ago7/16/24 to 7/16/251 Year Ago10/15/23 to 10/14/24Strong Buy1 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy6 Buy rating(s)5 Buy rating(s)5 Buy rating(s)4 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)0 Hold rating(s)0 Hold rating(s)Sell1 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$43.97$40.63$32.40$30.00Forecasted Upside7.24% Upside-0.11% Downside2.94% Upside14.55% UpsideConsensus RatingModerate BuyBuyBuyBuy AORT Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History AORT Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Artivion Stock vs. The CompetitionTypeArtivionMedical CompaniesS&P 500Consensus Rating Score 2.78 2.33 2.52Consensus RatingModerate BuyHoldModerate BuyPredicted Upside7.24% Upside1,016.41% Upside12.87% UpsideNews Sentiment RatingNeutral NewsSee Recent AORT NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails10/10/2025Citigroup3 of 5 stars Reiterated RatingOutperform10/10/2025JMP Securities3 of 5 starsDaniel Stauder Not RatedBoost TargetMarket Outperform$42.00 ➝ $47.00+16.57%10/8/2025Weiss Ratings0 of 5 stars Reiterated RatingSell (D-)9/29/2025Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRick WiseSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$40.00 ➝ $46.00+10.73%9/29/2025Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingWilliam PlovanicSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$41.00 ➝ $50.00+22.03%8/22/2025Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMike MatsonSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$45.00 ➝ $50.00+15.97%8/13/2025LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingJeff CohenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral$32.00 ➝ $38.80-11.23%8/8/2025OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingOutperform5/6/2025Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingD. StauderSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeStrong-Buy7/2/2024Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$28.00 ➝ $30.00+17.97% Get the Latest News and Ratings for AORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Artivion and its competitors with MarketBeat's FREE daily newsletter. Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:42 PM ET. AORT Forecast - Frequently Asked Questions What is Artivion's forecast for 2025? According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Artivion is $43.97, with a high forecast of $50.00 and a low forecast of $32.00. Should I buy or sell Artivion stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Artivion in the last year. There is currently 1 sell rating, 1 hold rating, 6 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AORT shares. Does Artivion's stock price have much upside? According to analysts, Artivion's stock has a predicted upside of 7.24% based on their 12-month stock forecasts. Has Artivion been downgraded by Wall Street analysts recently? Over the previous 90 days, Artivion's stock had 1 downgrade by analysts. What analysts cover Artivion? Artivion has been rated by research analysts at Canaccord Genuity Group, Citigroup, JMP Securities, LADENBURG THALM/SH SH, Needham & Company LLC, Oppenheimer, Stifel Nicolaus, and Weiss Ratings in the past 90 days. Do Wall Street analysts like Artivion more than its competitors? Analysts like Artivion more than other "medical" companies. The consensus rating for Artivion is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how AORT compares to other companies. Stock Forecasts and Research Tools Related Companies Stevanato Group Stock Forecast iRhythm Technologies Stock Forecast Bausch + Lomb Stock Forecast Glaukos Stock Forecast TransMedics Group Stock Forecast Envista Stock Forecast Soleno Therapeutics Stock Forecast LivaNova Stock Forecast Warby Parker Stock Forecast National Vision Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:AORT) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
